HYH2006078P1

HYH2006078P1 is an investigational small molecule sedative and anesthetic agent developed by Tiandi Hengyi Pharmaceutical. It is currently in Phase 1 clinical development for procedural sedation and anesthesia in patients undergoing non-intubated procedures. Administered intravenously, the drug is designed to provide rapid-acting sedation with a predictable recovery profile, potentially offering an alternative to standard agents like propofol or midazolam in the clinical setting of minor surgeries and diagnostic interventions. The development program includes dose-escalation studies in healthy volunteers to evaluate safety, tolerability, pharmacokinetics, and exploratory pharmacodynamics.